SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-178615
Filing Date
2024-07-12
Accepted
2024-07-12 16:42:06
Documents
24
Period of Report
2024-05-23
Items
Item 1.03: Bankruptcy or Receivership
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d854608d8k.htm   iXBRL 8-K 43207
2 EX-2.1 d854608dex21.htm EX-2.1 716524
3 EX-99.1 d854608dex991.htm EX-99.1 668891
4 EX-99.2 d854608dex992.htm EX-99.2 668358
8 GRAPHIC g854608g11g02.jpg GRAPHIC 19001
9 GRAPHIC g854608g11g03.jpg GRAPHIC 2910
10 GRAPHIC g854608g12g05.jpg GRAPHIC 586102
11 GRAPHIC g854608g12g06.jpg GRAPHIC 578443
12 GRAPHIC g854608g12g07.jpg GRAPHIC 320269
13 GRAPHIC g854608g14g04.jpg GRAPHIC 581314
14 GRAPHIC g854608g14g05.jpg GRAPHIC 585884
15 GRAPHIC g854608g14g06.jpg GRAPHIC 320119
  Complete submission text file 0001193125-24-178615.txt   6542167

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA phasq-20240523.xsd EX-101.SCH 2514
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE phasq-20240523_lab.xml EX-101.LAB 18699
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phasq-20240523_pre.xml EX-101.PRE 11685
27 EXTRACTED XBRL INSTANCE DOCUMENT d854608d8k_htm.xml XML 3900
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 241114980
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)